收藏切换
Research advances in nanodelivery system-mediated cancer treatment through the PI3K-AKT signaling pathway
收藏切换
Hai-han LIU, Ming-xia WEN, Chen-xu HOU, Ping-ping ZHANG*, Yu-qin LI*
Acta Pharmaceutica Sinica | 2026, 61(5) : 1573 - 1585
Less
收藏切换
Acta Pharmaceutica Sinica | 2026, 61(5): 1573-1585
• Reviews •
Research advances in nanodelivery system-mediated cancer treatment through the PI3K-AKT signaling pathway
Full
Hai-han LIU, Ming-xia WEN, Chen-xu HOU, Ping-ping ZHANG*, Yu-qin LI*
Affiliations
  • School of Pharmaceutical Sciences & Institute of Materia Medica, Shandong First Medical University & Shandong Academy of Medical Sciences, Jinan 250117, China
Published: 2026-05-12 doi: 10.16438/j.0513-4870.2025-0687
Outline
收藏切换

Aberrant activation of the phosphoinositide 3-kinase (PI3K)-AKT signaling pathway has been identified in numerous cancer types, contributing to uncontrolled cellular proliferation, inhibition of apoptosis, enhanced metastatic potential, and the development of resistance to chemotherapy and radiotherapy. Consequently, targeting the PI3K-AKT pathway has emerged as a promising therapeutic strategy. Current approaches to inhibit this pathway include small-molecule inhibitors, natural compounds, siRNAs, and miRNAs. However, these therapeutic approaches are often limited in clinical application due to prominent adverse effects, poor biological stability, low solubility, or lack of targeting ability. The integration of nanotechnology into drug delivery systems offers a compelling solution by improving drug stability and solubility, minimizing off-target accumulation, and enhancing tumor-specific targeting. Nanocarrier-based delivery of agents targeting the PI3K-AKT pathway holds the potential to improve therapeutic efficacy, mitigate drug-induced toxicity, sensitize tumors to conventional therapies, and ultimately enhance patient outcomes. This review provides a comprehensive overview of the PI3K-AKT signaling pathway and its oncogenic role, provides a detailed review of the latest progress of nano-based drug delivery system in cancer treatment based on pathways, and discusses future directions, aiming to inform and guide ongoing research in this field.

PI3K  /  AKT  /  cancer therapy  /  nano-based drug delivery system  /  cancer
刘海涵, 温明霞, 侯晨旭, 张平平, 李玉琴. 基于纳米递送系统的PI3K-AKT信号通路治疗癌症的研究进展. 药学学报, 2026 , 61 (5) : 1573 -1585 . DOI: 10.16438/j.0513-4870.2025-0687
Hai-han LIU, Ming-xia WEN, Chen-xu HOU, Ping-ping ZHANG, Yu-qin LI. Research advances in nanodelivery system-mediated cancer treatment through the PI3K-AKT signaling pathway[J]. Acta Pharmaceutica Sinica, 2026 , 61 (5) : 1573 -1585 . DOI: 10.16438/j.0513-4870.2025-0687
Year 2026 volume 61 Issue 5
184
84
Cite this Article
BibTeX
Article Info
doi: 10.16438/j.0513-4870.2025-0687
  • Receive Date:2025-06-18
  • Online Date:2026-09-21
  • Published:2026-05-12
Article Data
Affiliations
History
  • Received:2025-06-18
  • Revised:2025-08-12
Affiliations
    School of Pharmaceutical Sciences & Institute of Materia Medica, Shandong First Medical University & Shandong Academy of Medical Sciences, Jinan 250117, China
References
Share
https://castjournals.cast.org.cn/joweb/yxxb/EN/10.16438/j.0513-4870.2025-0687
Share to
QR

Scan QR to access full text

Cite this article
BibTeX
Citations
表12种不同金属材料的力学参数
科
Family
属数
Number of
genus
种数
Number of
species
占总种数比例
Percentage of
total species (%)
属
Genus
种数
Number of
species
占总种数比例
Percentage of total
species (%)
鹅膏菌科Amanitaceae 2 11 5.26 鹅膏菌属 Amanita 10 4.78
小菇科 Mycenaceae 2 12 5.74 丝盖伞属 Inocybe 5 2.39
多孔菌科 Polyporaceae 8 14 6.70 蜡蘑属 Laccaria 5 2.39
红菇科 Russulaceae 3 23 11.00 小皮伞属 Marasmius 6 2.87
小菇属 Mycena 11 5.26
光柄菇属 Pluteus 5 2.39
红菇属 Russula 17 8.13
栓菌属 Trametes 5 2.39
关闭全屏
  • BibTeX
  • EndNote
  • RefWorks
  • TxT